Therapeutic potential of resveratrol in Alzheimer's disease

BMC Neuroscience

Volumn 9, Issue SUPPL. 2, 2008, Pages

  Vingtdeux, Valérie ^a   Dreses Werringloer, Ute ^a   Zhao, Haitian ^a   Davies, Peter ^a,b   Marambaud, Philippe ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; AMYLOID BETA PROTEIN; ENDOTHELIN CONVERTING ENZYME; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN P53; RESVERATROL; SIRTUIN 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; ANTIOXIDANT; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; DEMENTIA; DIETARY INTAKE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG POTENCY; ENZYME ACTIVATION; GENETIC POLYMORPHISM; HUMAN; INCIDENCE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIMARY PREVENTION; PROTEIN DEGRADATION; RED WINE; RISK FACTOR; RISK REDUCTION; ANIMAL; CHEMISTRY; PATHOLOGY; REVIEW; WINE;

ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; DEMENTIA; FLAVONOIDS; HUMANS; NERVE DEGENERATION; PHENOLS; STILBENES; WINE;

EID: 57449120637     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-9-S2-S6     Document Type: Conference Paper

References (53)

1. Selkoe DJ Alzheimer's disease: Genes, proteins, and therapy Physiol Rev 2001, 81:741-766 11274343
2. Davies P A very incomplete comprehensive theory of Alzheimer's disease Ann N Y Acad Sci 2000, 924:8-16 10.1111/j.1749-6632.2000.tb05553.x 11193806
3. Goedert M Spillantini MG Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease Biochim Biophys Acta 2000, 1502:110-121 10899436
4. Hardy J Selkoe DJ The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002, 297:353-356 10.1126/science.1072994 12130773
5. Marambaud P Robakis NK Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation Genes Brain Behav 2005, 4:134-146 10.1111/j.1601-183X.2005.00086.x 15810902
6. Marambaud P Shioi J Serban G Georgakopoulos A Sarner S Nagy V Baki L Wen P Efthimiopoulos S Shao Z A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions EMBO J 2002, 21:1948-1956 125968 11953314 10.1093/ emboj/21.8.1948
7. Marambaud P Wen PH Dutt A Shioi J Takashima A Siman R Robakis NK A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations Cell 2003, 114:635-645 10.1016/j.cell.2003.08.008 13678586
8. Harrison T Churcher I Beher D gamma-Secretase as a target for drug intervention in Alzheimer's disease Curr Opin Drug Discov Devel 2004, 7:709-719 15503873
9. Tanzi RE Moir RD Wagner SL Clearance of Alzheimer's Abeta peptide: The many roads to perdition Neuron 2004, 43:605-608 15339642
10. Turner AJ Fisk L Nalivaeva NN Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration Ann N Y Acad Sci 2004, 1035:1-20 10.1196/annals.1332.001 15681797
11. Collen D Ham-Wasserman lecture: Role of the plasminogen system in fibrin-homeostasis and tissue remodeling Hematology (Am Soc Hematol Educ Program) 2001, 1-9 11722975
12. Ertekin-Taner N Ronald J Feuk L Prince J Tucker M Younkin L Hella M Jain S Hackett A Scanlin L Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene Hum Mol Genet 2005, 14:447-460 10.1093/hmg/ddi041 15615772
13. Melchor JP Pawlak R Strickland S The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration J Neurosci 2003, 23:8867-8871 14523088
14. Luchsinger JA Mayeux R Dietary factors and Alzheimer's disease Lancet Neurol 2004, 3:579-587 10.1016/S1474-4422(04)00878-6 15380154
15. Orgogozo JM Dartigues JF Lafont S Letenneur L Commenges D Salamon R Renaud S Breteler MB Wine consumption and dementia in the elderly: A prospective community study in the Bordeaux area Rev Neurol (Paris) 1997, 153:185-192 9296132
16. Truelsen T Thudium D Gronbaek M Amount and type of alcohol and risk of dementia: The Copenhagen City Heart Study Neurology 2002, 59:1313-1319 12427876
17. Luchsinger JA Tang MX Siddiqui M Shea S Mayeux R Alcohol intake and risk of dementia J Am Geriatr Soc 2004, 52:540-546 10.1111/ j.1532-5415.2004.52159.x 15066068
18. Lindsay J Laurin D Verreault R Hebert R Helliwell B Hill GB McDowell I Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging Am J Epidemiol 2002, 156:445-453 10.1093/aje/kwf074 12196314
19. Wang J Ho L Zhao Z Seror I Humala N Dickstein DL Thiyagarajan M Percival SS Talcott ST Pasinetti GM Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease FASEB J 2006, 20:2313-2320 10.1096/fj.06-6281com 17077308
20. Wenzel E Somoza V Metabolism and bioavailability of trans-resveratrol Mol Nutr Food Res 2005, 49:472-481 10.1002/mnfr.200500010 15779070
21. Walle T Hsieh F DeLegge MH Oatis JE Jr Walle UK High absorption but very low bioavailability of oral resveratrol in humans Drug Metab Dispos 2004, 32:1377-1382 10.1124/dmd.104.000885 15333514
22. Baur JA Sinclair DA Therapeutic potential of resveratrol: The in vivo evidence Nat Rev Drug Discov 2006, 5:493-506 10.1038/nrd2060 16732220
23. Lagouge M Argmann C Gerhart-Hines Z Meziane H Lerin C Daussin F Messadeq N Milne J Lambert P Elliott P Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 2006, 127:1109-1122 10.1016/j.cell.2006.11.013 17112576
24. Dasgupta B Milbrandt J Resveratrol stimulates AMP kinase activity in neurons Proc Natl Acad Sci USA 2007, 104(17):7217-7222 1855377 17438283 10.1073/pnas.0610068104
25. Baur JA Pearson KJ Price NL Jamieson HA Lerin C Kalra A Prabhu VV Allard JS Lopez-Lluch G Lewis K Resveratrol improves health and survival of mice on a high-calorie diet Nature 2006, 444:337-342 10.1038/nature05354 17086191
26. Pervaiz S Resveratrol: From grapevines to mammalian biology FASEB J 2003, 17:1975-1985 10.1096/fj.03-0168rev 14597667
27. Sun AY Chen YM James-Kracke M Wixom P Cheng Y Ethanol-induced cell death by lipid peroxidation in PC12 cells Neurochem Res 1997, 22:1187-1192 10.1023/A:1021968526696 9342721
28. Draczynska-Lusiak B Doung A Sun AY Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease Mol Chem Neuropathol 1998, 33:139-148 10.1007/BF02870187 9565971
29. Han YS Zheng WH Bastianetto S Chabot JG Quirion R Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: Involvement of protein kinase C Br J Pharmacol 2004, 141:997-1005 1574264 15028639 10.1038/sj.bjp.0705688
30. Jang JH Surh YJ Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death Free Radic Biol Med 2003, 34:1100-1110 10.1016/ S0891-5849(03)00062-5 12684095
31. Savaskan E Olivieri G Meier F Seifritz E Wirz-Justice A Muller-Spahn F Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity Gerontology 2003, 49:380-383 10.1159/000073766 14624067
32. Ahn JS Lee JH Kim JH Paik SR Novel method for quantitative determination of amyloid fibrils of alpha-synuclein and amyloid beta/A4 protein by using resveratrol Anal Biochem 2007, 367:259-265 10.1016/ j.ab.2007.05.023 17597573
33. Riviere C Richard T Vitrac X Merillon JM Valls J Monti JP New polyphenols active on beta-amyloid aggregation Bioorg Med Chem Lett 2008, 18:828-831 10.1016/j.bmcl.2007.11.028 18042380
34. Ono K Yoshiike Y Takashima A Hasegawa K Naiki H Yamada M Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: Implications for the prevention and therapeutics of Alzheimer's disease J Neurochem 2003, 87:172-181 10.1046/j.1471-4159.2003.01976.x 12969264
35. Riviere C Richard T Quentin L Krisa S Merillon JM Monti JP Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro Bioorg Med Chem 2007 15 1160 1167 10.1016/j.bmc.2006.09.069 17049256
36. Guarente L Calorie restriction and SIR2 genes - towards a mechanism Mech Ageing Dev 2005, 126:923-928 10.1016/j.mad.2005.03.013 15941577
37. Howitz KT Bitterman KJ Cohen HY Lamming DW Lavu S Wood JG Zipkin RE Chung P Kisielewski A Zhang LL Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 2003, 425:191-196 10.1038/nature01960 12939617
38. Chen D Steele AD Lindquist S Guarente L Increase in activity during calorie restriction requires Sirt1 Science 2005, 310:1641 10.1126/ science.1118357 16339438
39. Rodgers JT Lerin C Haas W Gygi SP Spiegelman BM Puigserver P Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 2005, 434:113-118 10.1038/nature03354 15744310
40. Nemoto S Fergusson MM Finkel T SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1alpha J Biol Chem 2005, 280:16456-16460 10.1074/jbc.M501485200 15716268
41. Kim D Nguyen MD Dobbin MM Fischer A Sananbenesi F Rodgers JT Delalle I Baur JA Sui G Armour SM SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis EMBO J 2007, 26:3169-3179 1914106 17581637 10.1038/ sj.emboj.7601758
42. Patel NV Gordon MN Connor KE Good RA Engelman RW Mason J Morgan DG Morgan TE Finch CE Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models Neurobiol Aging 2005, 26:995-1000 10.1016/ j.neurobiolaging.2004.09.014 15748777
43. Wang J Ho L Qin W Rocher AB Seror I Humala N Maniar K Dolios G Wang R Hof PR Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease FASEB J 2005, 19:659-661 10.1096/ fj.04-2370com 15650008
44. Qin W Chachich M Lane M Roth G Bryant M de Cabo R Ottinger MA Mattison J Ingram D Gandy S Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus) J Alzheimers Dis 2006, 10:417-422 17183154
45. Qin W Yang T Ho L Zhao Z Wang J Chen L Zhao W Thiyagarajan M MacGrogan D Rodgers JT Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction J Biol Chem 2006, 281:21745-21754 10.1074/jbc.M602909200 16751189
46. Marambaud P Zhao H Davies P Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides J Biol Chem 2005, 280:37377-37382 10.1074/jbc.M508246200 16162502
47. Abou-Agag LH Aikens ML Tabengwa EM Benza RL Shows SR Grenett HE Booyse FM Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells Alcohol Clin Exp Res 2001, 25:155-162 10.1111/ j.1530-0277.2001.tb02193.x 11236827
48. Yang SH Kim JS Oh TJ Kim MS Lee SW Woo SK Cho HS Choi YH Kim YH Rha SY Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray Int J Oncol 2003, 22:741-750 12632063
49. Nicholas SB Kawano Y Wakino S Collins AR Hsueh WA Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells Hypertension 2001, 37:722-727 11230363
50. Yan Q Zhang J Liu H Babu-Khan S Vassar R Biere AL Citron M Landreth G Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease J Neurosci 2003, 23:7504-7509 12930788
51. d'Abramo C Massone S Zingg JM Pizzuti A Marambaud P Dalla Piccola B Azzi A Marinari UM Pronzato MA Ricciarelli R Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death Biochem J 2005, 391:693-698 1276971 15946122 10.1042/BJ20050560
52. Camacho IE Serneels L Spittaels K Merchiers P Dominguez D De Strooper B Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide J Neurosci 2004, 24:10908-10917 10.1523/JNEUROSCI.3987-04.2004 15574741
53. Heneka MT Sastre M Dumitrescu-Ozimek L Hanke A Dewachter I Kuiperi C O'Banion K Klockgether T Van Leuven F Landreth GE Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice Brain 2005, 128:1442-1453 10.1093/brain/awh452 15817521